🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral GLP-1 pipeline overview — all agents in development Page 7

Oral GLP-1 pipeline overview — all agents in development

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 291 replies 50,237 viewsPage 7 of 20
mike_mealprep
Member
412
1,890
Jul 2024
Chicago, IL
Mar 10, 2024 at 10:12 PM#31
PharmacoVig_BOS said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

That reframing is the part I needed. I will report back once I have actually tried it.

19 17mia_MS2, LeilaHI, marcus_mpls and 16 others
Reply Quote Save Share Report
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Mar 11, 2024 at 9:33 PM#32

Clinical perspective, offered as context rather than as advice. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

20 18Dr.NateNeph, PharmD_Rodriguez, julia.endo and 17 others
Reply Quote Save Share Report
traveltech_sara
Member
156
678
Jan 2025
Remote, USA
Mar 12, 2024 at 8:53 PM#33
andrew_nyc said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

This matches mine closely enough to be worth saying so out loud. Nothing to add that would improve it.

21 19wanda_boise, NurseAsh_DET, BenResearch_OR and 18 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Mar 13, 2024 at 8:12 PM#34
andrew_nyc said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Coming at andrew_nyc’s question from a different direction. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

22 20roxy_nash, tony_orlando, Dr.NephBHM_UK and 19 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Mar 14, 2024 at 7:31 PM#35

The figures, for anyone assembling their own picture. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

Last edited: Mar 14, 2024 at 8:31 PM
23 21mike_nyc, VendorMark, COA_Karl and 20 others
Reply Quote Save Share Report
15678920

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register